In vitro and in vivo anti-melanoma effects of ciglitazone. (Q39889800)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

title

In vitro and in vivo anti-melanoma effects of ciglitazone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Philippe Bahadoran

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Thomas Botton

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Alexandre Puissant

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Jean-Sébastien Annicotte

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Sophie Tartare-Deckert

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Corine Bertolotto

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Robert Ballotti

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Lluis Fajas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

J-P Ortonne

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Genevieve Gozzerino

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

Stephane Rocchi

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

29 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

volume

129

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1208-1218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

Peroxisomal proliferator-activated receptor-gamma agonists induce partial reversion of epithelial-mesenchymal transition in anaplastic thyroid cancer cells

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Use of the peroxisome proliferator-activated receptor (PPAR) gamma ligand troglitazone as treatment for refractory breast cancer: a phase II study

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Peroxisome proliferator-activated receptor gamma activation induces cell cycle arrest via the p53-independent pathway in human anaplastic thyroid cancer cells

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Epidemiology and prevention of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Brn-2 expression controls melanoma proliferation and is directly regulated by beta-catenin

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Involvement of FKHRL1 in melanoma cell survival and death.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

IGF1 promotes resistance to apoptosis in melanoma cells through an increased expression of BCL2, BCL-X(L), and survivin

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Activation of caspase-3 and cleavage of Rb are associated with p16-mediated apoptosis in human non-small cell lung cancer cells

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

The many faces of PPARgamma

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Growth inhibition and differentiation induced by peroxisome proliferator activated receptor gamma ligand rosiglitazone in human melanoma cell line A375.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Peroxisome-proliferator-activated receptors and cancers: complex stories

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Antineoplastic potency of arylchloroethylurea derivatives in murine colon carcinoma.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Agonists of peroxisome proliferator-activated receptor gamma inhibit cell growth in malignant melanoma

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

PPAR-gamma ligands and amino acid deprivation promote apoptosis of melanoma, prostate, and breast cancer cells

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

The effect of PPAR?? ligands on the proliferation and apoptosis of human melanoma cells

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

SPARC represses E-cadherin and induces mesenchymal transition during melanoma development

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosis

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Thiazolidinediones: an update.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Living with or without cyclins and cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

The synthetic ligand of peroxisome proliferator-activated receptor-gamma ciglitazone affects human glioblastoma cell lines

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1.

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma

1 reference

https://api.crossref.org/works/10.1038/JID.2008.346

7 January 2021

Identifiers

DOI

10.1038/JID.2008.346

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19177142 AND SRC:MED&resulttype=core&format=json

release_5lxgqekdgnefhn34hkyk32zghy

20 January 2020

Fatcat ID

0 references

1 reference